These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3965701)

  • 41. Stereochemical requirements for central and peripheral muscarinic and antimuscarinic activity of some acetylenic compounds related to oxotremorine.
    Dahlbom R; Jenden DJ; Resul B; Ringdahl B
    Br J Pharmacol; 1982 Jun; 76(2):299-304. PubMed ID: 7093587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
    Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
    Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum.
    Nilvebrant L; Sparf B
    Scand J Gastroenterol Suppl; 1982; 72():69-77. PubMed ID: 6957999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of dissociation constants and relative efficacies of some potent muscarinic agonists at postjunctional muscarinic receptors.
    Grana E; Lucchelli A; Zonta F; Boselli C
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):8-11. PubMed ID: 3574495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M.
    Dallanoce C; Conti P; De Amici M; De Micheli C; Barocelli E; Chiavarini M; Ballabeni V; Bertoni S; Impicciatore M
    Bioorg Med Chem; 1999 Aug; 7(8):1539-47. PubMed ID: 10482446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands.
    De Amici M; Conti P; Fasoli E; Barocelli E; Ballabeni V; Bertoni S; Impicciatore M; Roth BL; Ernsberger P; De Micheli C
    Farmaco; 2003 Sep; 58(9):739-48. PubMed ID: 13679167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetics of solvolysis and muscarinic actions of an N-methyl-N-(2-bromoethyl)amino analogue of oxotremorine.
    Ringdahl B; Jenden DJ
    J Med Chem; 1987 May; 30(5):852-4. PubMed ID: 3572973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of 4-diphenylacetoxy-N-(2-chloroethyl)-piperidine (4-DAMP mustard) for estimating the apparent affinities of some agonists acting at muscarinic receptors in guinea-pig ileum.
    Barlow RB; McMillen LS; Veale MA
    Br J Pharmacol; 1991 Mar; 102(3):657-62. PubMed ID: 1364835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological properties of oxotremorine and its analogs.
    Ringdahl B; Jenden DJ
    Life Sci; 1983 May; 32(21):2401-13. PubMed ID: 6343743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification by hexamethonium of the muscarinic receptors blocking activity of pancuronium and homatropine in isolated tissues of the guinea-pig.
    Leung E; Mitchelson F
    Eur J Pharmacol; 1982 May; 80(1):11-7. PubMed ID: 6896494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand binding to muscarinic receptors in intact longitudinal muscle strips from guinea-pig intestine.
    Ward D; Young JM
    Br J Pharmacol; 1977 Oct; 61(2):189-97. PubMed ID: 922248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.
    Resul B; Lewander T; Ringdahl B; Zetterström T; Dahlbom R
    Eur J Pharmacol; 1982 May; 80(2-3):209-15. PubMed ID: 7106176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Displacement of [3H]oxotremorine-M binding by muscarinic antagonists in guinea-pig atrial and ileal membrane homogenates.
    Choo LK; Mitchelson F
    Eur J Pharmacol; 1988 Jul; 151(2):197-204. PubMed ID: 3169122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A difference in receptor mechanisms for muscarinic full and partial agonists.
    Takayanagi I; Harada M; Koike K
    Jpn J Pharmacol; 1991 May; 56(1):23-31. PubMed ID: 1880983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of 2 alpha-DHET and its optical isomers on muscarinic and nicotinic receptors.
    Gao ZG; Wang L; Liu CG
    Life Sci; 1995; 56(25):PL461-6. PubMed ID: 7791508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitation of the criticality of chiral centers toward stereoselective recognition: epimeric eudismic analysis of 1,3-oxathiolane muscarinic agonists and antagonists.
    Lehmann PA
    Chirality; 1990; 2(4):211-8. PubMed ID: 2083143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A test of the null equation for functional antagonism.
    Emmerson J; Mackay D
    Br J Pharmacol; 1981 May; 73(1):135-41. PubMed ID: 7284693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enzymatic resolution and cholinergic properties of (+/-)3-quinuclidinol derivatives.
    Rehavi M; Maayani S; Sokolovsky M
    Life Sci; 1977 Nov; 21(9):1293-302. PubMed ID: 927030
    [No Abstract]   [Full Text] [Related]  

  • 60. New methods for determining dissociation constants of agonist-receptor complexes.
    Venter DP
    Eur J Pharmacol; 1996 May; 303(3):235-46. PubMed ID: 8813575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.